Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
Clinical trial NCT02531308 · TERMINATED
Trial details
- NCT number
- NCT02531308
- Sponsor
- Rush University Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.